ACA

NEUTRALM&A

Arcosa, Inc.

2026-09-01

Price

$145.48

+0.12%

This is the 2026-09-01 snapshot — the signals and analysis for ACA as of this single trading day.

View full ACA research hub →

Score11.5Top Tier

Signals6/8 DNA1/13 Act · 0/4 Risk

SentimentNEUTRALScore: 8

Volume1.1xvs 20d avg

Analysis

Arcosa's (ACA) exceptionally low volatility and perfect technical stacking are the direct result of its pending $150 per share all-cash acquisition by CRH. The stock is pinned in a tight arbitrage channel, drifting slightly higher as the September 4th stockholder vote approaches. The current RISK_ON macro regime provides immense conviction for this setup; with credit spreads remaining exceptionally tight at 0.80%, the market is signaling zero stress regarding CRH's $5.75 billion bridge financing, virtually eliminating deal-break risk tied to liquidity.

Fired Signals

ALPHA MALEQUIET STORMSTEADY CLIMBGOLDEN CROSSMARKET LEADERPERFECT STACKINSIDE OUT

Key Takeaways

Merger Arbitrage Opportunity: ACA is trading at a ~$4.50 discount to CRH's $150 all-cash acquisition offer, offering a defined yield as the deal approaches closure [2.1.1].
Credit Market Confirmation: Tight corporate credit spreads (0.80%) ensure CRH's $5.75 billion bridge loan financing remains highly secure despite global geopolitical noise.
Imminent Catalyst: A special stockholder meeting is scheduled for September 4, 2026, serving as the primary near-term hurdle for the $8.5 billion acquisition.

← Back to 2026-09-01 View Full ACA History →Yahoo Finance &nearr;